Laryngeal leishmaniasis
Authors:
- 1 September 1994
- journal article
- case report
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 108 (12) , 1086-1088
Abstract
A patient suffering from persistent hoarseness was eventually shown to have laryngeal leishmaniasis. The incubation period for the disease must have been at least 16 years, following infection in Southern Europe. Mucosal leishmaniasis is rare in the Eastern hemisphere, and laryngeal leishmaniasis has not previously been reported in the UK. Previous Mediterranean cases have run a similar chronic course and have caused diagnostic difficulty, in particular being mistaken for malignancy. Treatment with aminosidine was ineffective, but the patient responded to liposomal amphotericin.Keywords
This publication has 9 references indexed in Scilit:
- Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United KingdomTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Amphotericin versus pentamidine in antimony-unresponsive kala-azarThe Lancet, 1992
- Liposomal amphotericin B in the treatment of visceral leishmaniasisJournal of Antimicrobial Chemotherapy, 1991
- Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconateTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Leishmaniasis donovani Presenting as an Isolated Lesion in the LarynxORL, 1986
- Ecologie des Leishmanioses dans le sud de la FranceAnnales de Parasitologie Humaine et Comparée, 1980
- Sudan mucosal leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1975
- Onset of espundia after many years of occult infection with Leishmania braziliensisThe American Journal of Tropical Medicine and Hygiene, 1973
- Leishmaniasis of the larynxThe American Journal of Medicine, 1961